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ABSTRACT: In view of the growing worldwide rise in microbial
resistance, there is considerable interest in designing new antimicrobial
copolymers. The aim of the current study was to investigate the
relationship between antimicrobial activity and copolymer composition/
architecture to gain a better understanding of their mechanism of action.
Speciﬁcally, the antibacterial activity of several copolymers based on 2-
(methacryloyloxy)ethyl phosphorylcholine [MPC] and 2-hydroxypropyl
methacrylate (HPMA) toward Staphylococcus aureus was examined. Both
block and graft copolymers were synthesized using either atom transfer
radical polymerization or reversible addition−fragmentation chain
transfer polymerization and characterized via 1H NMR, gel permeation
chromatography, rheology, and surface tensiometry. Antimicrobial
activity was assessed using a range of well-known assays, including
direct contact, live/dead staining, and the release of lactate dehydrogen-
ase (LDH), while transmission electron microscopy was used to study the morphology of the bacteria before and after the
addition of various copolymers. As expected, PMPC homopolymer was biocompatible but possessed no discernible antimicrobial
activity. PMPC-based graft copolymers comprising PHPMA side chains (i.e. PMPC-g-PHPMA) signiﬁcantly reduced both
bacterial growth and viability. In contrast, a PMPC−PHPMA diblock copolymer comprising a PMPC stabilizer block and a
hydrophobic core-forming PHPMA block did not exhibit any antimicrobial activity, although it did form a biocompatible worm
gel. Surface tensiometry studies and LDH release assays suggest that the PMPC-g-PHPMA graft copolymer exhibits surfactant-
like activity. Thus, the observed antimicrobial activity is likely to be the result of the weakly hydrophobic PHPMA chains
penetrating (and hence rupturing) the bacterial membrane.
■ INTRODUCTION
The overuse of antibiotics has led to a worldwide rise in
bacterial resistance over several decades with the specter of
untreatable infections now looming ever closer.1−4 Some
infections pose particular therapeutic diﬃculties, which have
resulted in various antibiotics becoming ineﬀective. For
example, treatment of low-grade or chronic wound infections
has led to nonantibiotic treatments being sought. Among these
are the topical application of honey,5−9 silver,10−13 and cationic
copolymers.14−22 However, these approaches do not oﬀer a
panacea (e.g., silver may compromise wound healing and honey
can be diﬃcult to handle), so there is a clinical need to develop
new therapies.23 For this reason, biocompatible materials that
are intrinsically antimicrobial and can be easily incorporated
into dressings would be useful additions to the therapeutic
arsenal for treating infected wounds.
Modern wound dressings employ various polymeric
biomaterials,11,13,24−26 including hydrogels. The latter have
the advantages of retaining moisture, exhibiting low cytotox-
icity, cooling the wound to reduce pain, being highly absorbent,
and, as we describe herein, some may possess inherent
antimicrobial activity.26−29 Certain biomimetic polymers can
mimic the chemical structure of mammalian cell membranes,
which make them ideal candidates for in vivo biomedical
applications where biocompatibility is of paramount impor-
tance.16,19,26,30,31
We have previously reported that thermoresponsive
PHPMA−PMPC−PHPMA triblock copolymer gelators
[where MPC = 2-(methacryloyloxy)ethyl phosphorylcholine
and HPMA = 2-hydroxypropyl methacrylate] can serve as
biocompatible gelators for novel wound dressings.31,32 More-
over, these particular copolymer gels exhibited unexpected
antimicrobial activity toward Staphylococcus aureus and other
micro-organisms. In principle, several physicochemical proper-
ties of these novel copolymer gels may be important for the
observed antimicrobial activity. It was shown that the PHPMA
component was essential for this activity but the precise mode
of action was unknown. Previously, we reported that a range of
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micro-organisms were killed/inhibited by a PHPMA88−
PMPC400−PHPMA8 triblock copolymer gelator.
32 In the
present study, we examine how the architecture of several
types of PHPMA-based copolymers inﬂuences antibacterial
performance and probe the mechanism of action. To address
these two fundamental questions, we chose to focus on a single
micro-organism, S. aureus.
The aim of the present study is to explore in more detail the
relationship between antimicrobial activity and the copolymer
composition/architecture of this potentially useful class of
biomaterials.
■ MATERIALS
2-(Methacryloyloxy)ethyl phosphorylcholine monomer (MPC, 99.9%
purity) was donated by Biocompatibles U.K. Ltd. (Farnham, U.K.). 2-
Hydroxypropyl methacrylate (HPMA) was donated by GEO Specialty
Chemicals (Hythe, U.K.). Bis(2-hydroxyethyl)disulﬁde (98%), 2-
bromoisobutyryl bromide (98%), 4-vinylbenzyl chloride, basic alumina
(Brockmann I, standard grade, 150 mesh, 58 Å), anhydrous methanol
(99.8%), copper chloride (Cu(I)Cl, 99.995%), copper bromide
(Cu(I)Br, 99.9%), and 2,2-bipyridine (bpy, 99%), triethylamine
(99%), cetyltrimethylammonium bromide (CTAB), and cresyl violet
acetate (70%) were purchased from Sigma-Aldrich U.K. (Dorset,
U.K.). All these chemicals were used as received, except for
triethylamine, which was reﬂuxed over potassium hydroxide and
kept sealed over potassium hydroxide. The silica gel 60 (0.063−0.200
μm) used to remove the spent ATRP catalyst was purchased from E.
Merck (Darmstadt, Germany). Propan-1,3-diol was purchased from
Hopkins and Williams (London, U.K.). All solvents were HPLC-grade
and purchased from Fisher Scientiﬁc (Loughborough, U.K.).
Deionized water was used in all experiments.
Three strains of S. aureus were employed in this study: NCTC 6571
(Oxford), S235, and L9879. The former is a laboratory standard strain
used in sensitivity assays, strain S235 is a clinical isolate, and strain
L9879 is relatively hydrophilic compared with the other two strains.
The latter was included because it was hypothesized that this feature
might inﬂuence its interaction with the copolymer gels. The culture
medium, Brain Heart Infusion (BHI) broth, and agar were purchased
from Oxoid (Basingstoke, U.K.). Live/dead staining was performed
using propidium iodide (PI) and Syto 9, which were purchased from
Invitrogen (Paisley, U.K.). Dulbecco’s modiﬁed Eagle’s medium
(DMEM) and EDTA were purchased from Sigma-Aldrich (Poole,
Dorset, U.K.). Fetal calf serum (FCS) was purchased from Labtech
(Ringmer, U.K.). Glutamine, penicillin, and streptomycin were
purchased from Gibco (Paisley, U.K.). MTT (3-(4,5-dimethylthiazol-
2-yl)-2,5 diphenyl tetrazolium bromide) powder, MTS 3-(4,5-
dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-
2H-tetrazolium, and Lysostaphin were purchased from Sigma-Aldrich
(Dorset, U.K.). Isopropanol and 7-hydroxy-3H-phenoxazin-3-one 10-
oxide (Resazurin−Alamar Blue) were purchased from Fisher Scientiﬁc
(Leicestershire, U.K.). Trypsin was purchased from Difco Laboratories
(Detroit, MI, U.S.A.). An LDH-Cytotoxicity Assay Kit II was
purchased from Abcam (Abcam, U.K.)
Homopolymerization of HPMA by ATRP. PHPMA homopol-
ymer was prepared via ATRP with a target degree of polymerization
(DP) of 50. More speciﬁcally, HPMA monomer (20.0 g, 0.139 mol),
2-(dimethylamino)ethyl-2-bromoisobutyrylamide initiator (prepared
as described previously;33 1.09 g, 4.63 mmol), bpy (1.44 g, 9.26
mmol), and a 90:10 v/v IPA/H2O mixture (20 mL) were placed in a
round-bottomed ﬂask. This was placed on ice and degassed by purging
with nitrogen through a needle for 30 min. Then Cu(I)Cl (0.463 g,
4.63 mmol) was added quickly to the stirred solution under a positive
nitrogen pressure and the reaction solution was heated to 50 °C in an
oil bath for 24 h. The reaction solution was exposed to air, cooled, and
diluted with methanol. This quenching protocol resulted in a change
in color from dark brown to blue/green, which indicated aerial
oxidation of the catalyst. The solution was passed through a short silica
column and washed repeatedly with methanol to remove the spent
Cu(I)Cl. Solvent evaporation using a rotary evaporator and drying on
a vacuum line overnight aﬀorded a tertiary amine-functionalized
PHPMA homopolymer as a white powder.
Quaternization of PHPMA Macromonomer. PHPMA homo-
polymer (23.9 g, 5.54 mmol) was dissolved in methanol (12.6 mL) to
give a 25% w/v solution. To this solution, 4-vinylbenzyl chloride (4-
VBC; 2.54 g, 16.6 mmol; VBC/PHPMA molar ratio = 3.0) was added
and the reaction mixture was stirred at 20 °C for 48 h. Excess 4-VBC
was then removed by precipitation three times into cyclohexane (700
mL). Residual solvent was removed by rotary evaporation and the
resulting solid was recovered and dried on a vacuum line overnight.
The resulting puriﬁed styrene-functionalized PHPMA macromonomer
was characterized by 1H NMR spectroscopy. The mean degree of
quaternization was calculated by comparing the aromatic styrene end-
group signals at δ 7.55−7.70 to the two azamethylene protons assigned
to the tertiary amine end-group of the PHPMA chain at δ 3.61−3.77.25
Cresyl Violet-Labeled PHPMA Macromonomer by ATRP.
Fluorescently labeled macromonomers were prepared by the addition
of cresyl violet (CV; λem = 600 nm) in its acetate salt form. This dye
functions as a chain transfer agent that reacts irreversibly with the
propagating PHPMA radicals, thus adding the ﬂuorescent label at the
end of the propagating chain-end. Care was taken to minimize
exposure to light during this synthesis. HPMA (20.0 g, 0.138 mol), 2-
(dimethylamino)ethyl-2-bromoisobutyrylamide initiator (0.658 g, 2.77
mmol), and cresyl violet acetate (0.223 g, 2.77 mmol) were dissolved
in a 90:10 IPA/H2O v/v mixture (20 mL) and the resulting solution
was cooled on ice, degassed, and kept under a nitrogen atmosphere for
40 min. Cu(I)Cl (0.275 g, 2.77 mmol) and bpy (0.866 g, 5.55 mmol)
were then added and the solution was heated to 50 °C in an oil bath
and stirred for 24 h, at which point samples were taken for 1H NMR
and dimethylformamide gel permeation chromatography (GPC). The
resulting CV-terminated PHPMA homopolymer precursor was
dissolved in methanol and passed through a silica column to remove
the spent catalyst as well as any free CV dye. Excess solvent was
removed via rotary evaporation to aﬀord a purple solid.
Synthesis of 1,3-Bis(2-(thiobenzoylthio)prop-2-yl)benzene
[TBTPB]. TBTPB was synthesized according to previously reported
methods.34 Dithiobenzoic acid (DTBA) was synthesized as described
previously.35 DTBA (48.0 g, 0.311 mol, 1.0 equiv), 1,3-diisoprope-
nylbenzene (49.0 g, 0.311 mol, 1.0 equiv), p-toluenesulfonic acid (2.00
g, 2.0% w/v), and CCl4 (160 mL) was mixed under a nitrogen
atmosphere and reﬂuxed for 18 h at 75 °C in an oil bath. After cooling
to room temperature, a saturated solution of NaHCO3 (200 mL) was
added. After extraction with dichloromethane (2 × 100 mL) the
organic layers were combined, washed with a saturated sodium
chloride solution (400 mL) and dried over MgSO4 before being
evaporated under reduced pressure by rotary evaporation to aﬀord a
dark purple oil/solid. The crude product was further puriﬁed by
column chromatography on a 20 g scale using neutral silica as a
stationary phase and a mixed eluent comprising ethyl acetate and
petroleum ether using a gradient of ethyl acetate ranging from 5 to
10%. This procedure was repeated twice to aﬀord suﬃcient purity as
judged by TLC (yield: 86 g, 87%).
Preparation of PMPC300 Homopolymer by RAFT Polymer-
ization. TBTPB (0.0485 g, 0.104 mmol, 1.0 equiv) and MPC
monomer (5.00 g, 31.2 mmol, 300.0 equiv) were dissolved in ethanol
(3.37 mL) to produce a 40% w/v solution in a round-bottom ﬂask.
The ﬂask was then placed on ice and purged with nitrogen for 15 min.
Once degassed, the ﬂask was removed from the ice, ACVA (0.0073 g,
26.0 μmol, 0.25 equiv) was added, and the solution was degassed
further for 5 min. The reaction solution was heated to 80 °C in an oil
bath. Samples were removed regularly for 1H NMR and GPC analysis.
At high monomer conversion, the solution was cooled and exposed to
air. The crude homopolymer was diluted with methanol, dialyzed
(dialysis membrane molecular weight cut-oﬀ = 1000 Da) ﬁrst against
methanol and then against deionized water. An aqueous solution of
the puriﬁed PMPC homopolymer was then frozen in a round-
bottomed ﬂask using a liquid nitrogen bath before being freeze-dried
overnight. PMPC300 was recovered as a light pink solid (yield: 4.9 g,
97%).
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PMPC300-g-4(PHPMA50) Graft Copolymer by RAFT Polymer-
ization. PMPC300-g-4(PHPMA50) graft copolymers were prepared via
a one-pot synthesis using a bifunctional RAFT agent (TBTPB). The
copolymer was targeted with an overall DP of 300 MPC units plus
four PHPMA50 macromonomer units per backbone: PHPMA50
macromonomer (3.26 g, 0.452 mmol, 4.0 equiv) was dissolved in
ethanol (19 mL) by the aid of ultrasonication. This solution was added
to a round-bottomed ﬂask containing TBTPB (0.0308 g, 1.13 × 10−4
mol, 1.0 equiv) and MPC monomer (10.0 g, 3.39 × 10−2 mol, 300.0
equiv) to aﬀord a 40% w/v solution. The ﬂask was then placed on ice
and purged with nitrogen for 30 min. Once degassed, the ﬂask was
removed from the ice and ACVA (0.0079 g, 2.82 × 10−5 mol, 0.25
equiv) was added and the ﬂask was degassed further for 5 min. The
reaction solution was heated to 80 °C using an oil bath. Samples were
extracted over time for 1H NMR and GPC analysis. After 48 h, 1H
NMR showed very little residual monomer. At this point, the solution
was cooled and exposed to air. The copolymer was diluted with
methanol, dialyzed using a dialysis membrane (MWCO = 1000 Da)
ﬁrst against methanol and then deionized water. The puriﬁed
copolymer was then frozen in a round-bottom ﬂask using liquid
nitrogen before being freeze-dried overnight. PMPC300-g-4-
(PHPMA50) was recovered as a light pink solid (12.2 g, 92% yield).
A similar protocol was used to prepare an equivalent graft copolymer
using the CV-labeled PHPMA macromonomer described above. This
additional sample is denoted as “PMPC300-g-4(cvPHPMA50)”.
PMPC25−PHPMA275 Diblock Copolymer Worms. The
PMPC25−PHPMA275 worms were synthesized as described previ-
ously.36
PHPMA88-PMPC400−PHPMA88 Triblock Copolymer. The
PHPMA88−PMPC400−PHPMA88 triblock copolymer was synthesized
using a bifunctional disulﬁde-based ATRP initiator, as described
previously.31
1H NMR Spectroscopy. 1H NMR spectra were recorded in
CD3OD at 20 °C using a Bruker DPX-400 NMR spectrometer.
Spectra were analyzed using SpinWorks3 software (2010 Kirk Marat,
University of Manitoba, Canada).
Molecular Weight Determination. Molecular weight distribu-
tions were assessed at 40 °C using a Hewlett-Packard HP1090 liquid
chromatograph pump in combination with two Polymer Laboratories
PL Gel 5 μm Mixed-C (7.5 × 300 mm) columns in series with a guard
column connected to a Gilson Model 131 refractive index detector.
The eluent was a 3:1 v/v chloroform/methanol mixture containing 2.0
mM LiBr at a ﬂow rate of 1.0 mL min−1. Calibration was achieved
using a series of near-monodisperse poly(methyl methacrylate)
[PMMA] standards. Copolymers were dissolved in this mixed eluent
at a concentration of 5 mg dm−3 and ﬁltered before injection. Data
analyses were conducted using CirrusTM GPC Software supplied by
Polymer Laboratories.37
Gel Rheology Studies. These measurements were conducted as
described previously.37 Copolymer dispersions of varying concen-
tration were prepared by addition of aqueous phosphate buﬀered
saline (PBS) solution at 0 °C followed by vigorous shaking and storage
at 4 °C overnight prior to analysis. A Rheometric Scientiﬁc SR-5000
rheometer, equipped with a cone−plate geometry (40.0 mm, 0.05
radians) and a Peltier unit for temperature control, was used to
perform the oscillatory temperature sweeps. This was conducted at a
frequency of 1.0 rad s−1, an applied stress of 0.50 Pa, and a heating rate
of 3 °C min−1 from 5 to 50 °C.
Surface Tensiometry. All copolymers were dissolved in deionized
water at concentrations ranging from 5.0 × 10−4 % to 1.0% w/v and
stirred overnight to ensure full dissolution. These were compared with
control solutions of cetyltriammonium bromide (CTAB), a well-
known cationic surfactant, over the same concentration range. Surface
tensions were determined using a Lauda TD3 surface tensiometer at
various temperatures controlled by a water bath. The Du Nouy
method was utilized, which required a Pt ring (circumference = 4 cm).
Prior to each measurement, the Pt ring was washed in ethanol and
water after burning oﬀ any organic residue. The ring was then lowered
into each aqueous solution until the ring was located approximately 5
mm below the liquid surface. The surface tension was determined as
the minimum normal detachment force required to remove the Pt ring
from the water surface. Measurements were repeated six times per
sample and the results were averaged.
Cell Culture Studies. Human skin was obtained from patients
undergoing breast reductions and abdominoplasty elective surgical
procedures who gave informed consent for skin not required for their
treatment to be used on an anonymous basis for research as part of a
Human Research Tissue Bank [HTA] license number 12179.
Fibroblasts were isolated from skin according to the methods
described by Ghosh et al.38 Fibroblasts were isolated and cultured in
Dulbecco’s Modiﬁed Eagle’s Medium (DMEM), supplemented with
10% v/v fetal calf serum (FCS), 2.0 mmol dm−3 glutamine, 0.625 mg
dm−3 amphotericin B, 100 mg dm−3 streptomycin and 100 IU/mL
penicillin.2 Cell viability and metabolic activity were assessed using
Alamar Blue. Monolayers were washed three times in PBS and
incubated with 1.0 g dm−3 Alamar Blue solutions in a 24-well plate for
60 min at 37 °C with 5% CO2. The eluted dye was transferred to a 96-
well plate. The absorbance of each solution was determined at 540 nm
using a spectrophotometer.
Antimicrobial Assays. Staphylococcus aureus strains NCTC 6571
(Oxford), S235, and L9879 were cultured on brain heart infusion
(BHI)) agar or in BHI broth at 37 °C for 16 h, as required.
Direct Contact Assay. This involved placing copolymer onto
bacterial ﬁlms on BHI agar. A single colony of S. aureus was suspended
in 10 mL of sterile PBS and evenly distributed over the surface of BHI
agar plates with a swab. Dilutions of appropriate copolymer
preparations (5 to 20% w/v of PMPC-based statistical, block or
graft copolymers, respectively) were then pipetted in 10 μL aliquots
directly onto the surface of the bacterial ﬁlms at 4 °C before incubating
at 37 °C overnight. The resulting culture was assessed for its eﬀect on
bacterial growth.
Live/Dead Staining. Fluorescently labeled PMPC300-g-4-
(PHPMA50) graft copolymer was dissolved in PBS to produce a
12% w/w gel. Aliquots of S. aureus suspension (1 × 106 CFU) were
pelletized via centrifugation, resuspended in cold copolymer solution
and incubated overnight at 37 °C. Samples were then cooled on ice for
10 min to convert the thermoresponsive copolymer gel into a liquid.
Bacteria were then separated from the copolymer by centrifugation at
13 000 rpm at 4 °C for 4 min. The bacteria were incubated with the
ﬂuorescent dyes Syto 9 [1.5 μL of 3.34 mM solution in DMSO] and
PI [1.5 μL of 20 mM solution in DMSO] for 30 min before washing
excess dye from the bacteria three times using PBS. The bacteria were
then examined using a ﬂuorescence ZEISS LSM 510 M confocal
microscope with excitation wavelengths of 488 and 543 nm. Emission
spectra were recorded between 515 and 615 nm. The PI dye can only
traverse damaged membranes while the Syto 9 dye diﬀuses into all
cells, thus diﬀerentiating dead (red) cells from live (green) cells.
Confocal images were analyzed using LSM Image Browser software
(Carl Zeiss).
Lactate Dehydrogenase (LDH) Assay. Bacterial viability
following exposure to copolymer was also assessed by monitoring
the release of lactate dehydrogenase (LDH). S. aureus S235 (150 μL;
OD = 1.50, 1 × 108) was incubated overnight either with a 12% w/v
PMPC300-g-4(PHPMA50) aqueous dispersion or with an equal volume
(150 μL 1% w/v 1 mg/mL) of a positive control of glycylglycine
metalloendopeptidase, (lysostaphin). Samples were incubated 37 °C
for 18 h, cooled on ice for 10 min to convert the copolymer gel into a
free-ﬂowing liquid, and centrifuged at 13 000 rpm at 4 °C for 4 min to
sediment the bacteria. Aliquots of copolymer supernatant (50 μL)
were removed and assayed for LDH activity using a commercial LDH-
Cytotoxicity Assay Kit II (Abcam Ltd.) by recording the optical
density using a plate reader operating at 495 nm.
Transmission Electron Microscopy (TEM). Bacteria were
exposed to a 12% w/v aqueous PMPC300-g-4(PHPMA50) copolymer
gel and then isolated using the protocol described above. Copper TEM
grids (Agar Scientiﬁc, U.K.) were surface-coated with a thin ﬁlm of
amorphous carbon and then plasma glow-discharged for 30 s to create
a hydrophilic surface. Droplets (5.0 μL) of the bacteria suspensions
obtained from the LDH assay described above were adsorbed onto the
freshly glow-discharged grids, air-dried, and then blotted with ﬁlter
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paper to remove excess solution. Grids were rinsed with distilled water,
stained with uranyl formate (0.75% w/v) for 20 s, and then carefully
blotted to remove excess stain. After washing twice with deionized
water and drying under high vacuum, imaging was performed at 100
kV using a Phillips CM100 instrument equipped with a Gatan 1 k
CCD camera.
■ RESULTS AND DISCUSSION
In order to prepare well-deﬁned PMPC300-g-4(PHPMA50) graft
copolymers, near-monodisperse PHPMA macromonomers
were ﬁrst prepared using atom transfer radical polymerization
(ATRP) via a two-step synthetic route previously reported by
Armes and co-workers.39,40 First, HPMA was polymerized
using a tertiary amine-functionalized ATRP initiator in
methanol at 20 °C to produce a PHPMA homopolymer
precursor. Then the terminal tertiary amine group was
quaternized using excess 4-vinylbenzyl chloride (4-VBC) in
methanol at 20 °C to aﬀord the desired near-monodisperse
styrene-functionalized PHPMA macromonomer.33 Optionally,
cresyl violet was incorporated into the PHPMA macro-
monomers as a ﬂuorescent end-group to enable ﬂuorescent
visualization when investigating biological activity. Cresyl violet
acetate acts as a spin trap and reacts irreversibly with the
propagating PHPMA radicals, thus adding the desired
ﬂuorescent label to the end of the chain. Finally, the PHPMA
macromonomer was statistically copolymerized with MPC to
produce the ﬁnal PMPC-g-4(PHPMA50) graft copolymer using
RAFT polymerization via a grafting-through process. The target
PHPMA content was four macromonomer chains per
copolymer backbone for these model graft copolymers, which
is twice the number of PHPMA blocks per copolymer chain
compared to the PHPMA−PMPC−PHPMA triblock copoly-
mers reported earlier.31,32,41 This graft copolymer composition
was selected in order to produce an eﬃcient gelator.
The synthesis of the PMPC25−PHPMA275 diblock copoly-
mer worms is based on the principle of polymerization-induced
self-assembly (PISA), as reported by Sugihara et al.36 First, a
well-deﬁned PMPC25 macromolecular chain transfer agent
(macro-CTA) was prepared by conventional RAFT solution
polymerization of MPC in water. Then this macro-CTA was
used for the RAFT aqueous dispersion polymerization of
HPMA at 70 °C. To ensure reproducible targeting of the worm
phase, Sugihara et al. found it necessary to use a relatively short
PMPC block and also had to construct a detailed phase
diagram.36 The resulting PMPC25−PHPMA275 diblock copoly-
mer worms were used as a control in the present study and
Figure 1. Various copolymer compositions and architectures examined in this study: (a) PMPC300 homopolymer control; (b) PHPMA88−
PMPC400−PHPMA88 triblock copolymer; (c) PMPC300-g-4(PHPMA50); (d) PMPC25−PHPMA275 worms (control).
Table 1. Summary of Target Copolymer Compositions, Monomer Conversions, Molecular Weight Data, and Biological
Activities for the PMPC Homopolymer, the PMPC25−PHPMA275 Diblock Copolymer, PHPMA88−PMPC400−PHPMA88
Triblock Copolymer, and the PMPC300-g-4(PHPMA50) Graft Copolymer Examined in This Study
copolymer composition synthesis method conversion [1H NMR] Mw/Mn
a Mn [kg/mol] gel? biocompatible? antimicrobial?
PMPC300 RAFT 98% 1.21 40.8 no yes no
PMPC25−PHPMA275 RAFT 99% 1.29 72.0 yes yes no
PHPMA88−PMPC400−PHPMA88 ATRP 96% 1.35 89.5 yes yes yes
PMPC300-g-4(PHPMA50) RAFT 96% 1.33 78.6 yes yes yes
aGPC analysis using a refractive index detector, a 3:1 CHCl3/methanol mixed eluent containing 2.0 mM LiCl, and a series of near-monodisperse
poly(methyl methacrylate) (PMMA) calibration standards.
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formed soft free-standing aqueous gels at a copolymer
concentration of around 10% w/w at 20 °C.36
MPC was selected as a comonomer for this study because of
its well-known biocompatibility and well-controlled (co)-
polymerization using living radical polymerization techniques
such as ATRP or RAFT polymerization.42−53 A schematic
representation of the various copolymers used in this study is
depicted in Figure 1.
Table 1 summarizes the (co)polymers prepared in this study.
As expected, the PMPC homopolymer prepared via RAFT
polymerization did not form an aqueous gel. Another important
reference material for the present study was PMPC25−
PHPMA275, which self-assembles to form highly anisotropic
worm-like particles in aqueous solution.36 Multiple interworm
contacts are formed, leading to the formation of a soft free-
standing gel. Although relatively short, the highly hydrophilic
PMPC block acts as an eﬀective steric stabilizer for the worms,
while the relatively long, weakly hydrophobic PHPMA block
forms the worm cores. Thus, this copolymer was expected to be
biocompatible but to possess little or no antimicrobial activity.
In contrast, the ﬁnal two entries shown in Table 1 are
PMPC300-g-4(PHPMA50) graft copolymers prepared via RAFT
statistical copolymerization of MPC with the PHPMA50
macromonomer. These copolymers comprise a relatively long
PMPC-based backbone (target mean degree of polymerization
= 300) with a statistical distribution of approximately four
pendant PHPMA50 chains. This architecture can be compared
to the PHPMA−PMPC−PHPMA triblock copolymers pre-
viously reported by Madsen and co-workers.31 In both cases,
near-molecular dissolution can be achieved in cold aqueous
solution (below 5 °C), with self-assembly occurring on
warming to ambient temperature as the PHPMA blocks
become increasing hydrophobic.
Relatively low copolymer polydispersities were obtained for
PMPC homopolymer, the PMPC25-PHPMA275 diblock copoly-
mer, and the PMPC-based graft copolymers, as expected for
such pseudoliving polymerizations.54,55 The cresyl violet-
labeled PHPMA50 macromonomer was successfully incorpo-
rated into the graft copolymer chains. However, regardless of
whether a labeled or an unlabeled macromonomer was used,
the statistical copolymerization of MPC with PHPMA50
macromonomer was signiﬁcantly slower than the homopoly-
merization of MPC under the same conditions (see Figure 2).
More speciﬁcally, more than 40 h were required to achieve high
monomer conversions (at least 96%) when the PHPMA50
macromonomer was used, compared to less than 3 h without
this comonomer. Further work is required to understand these
perplexing observations, which we are currently unable to
explain; it is particularly surprising given that there are relatively
few macromonomer chains per graft copolymer chain (MPC/
styrene molar ratio = 75).
The thermoresponsive PMPC300-g-4(PHPMA50) graft co-
polymer gels were characterized by rheological measurements
using a cone-and-plate geometry setup. A temperature sweep
was performed for each copolymer between 2 and 40 °C in
which an oscillatory stress of 0.50 Pa was applied at a frequency
of 1.0 rad s−1 using a heating ramp rate of 3 °C min−1. The
storage (G) and loss (G) moduli exhibit diﬀering temper-
ature-dependent behavior and the point at which G crosses G
indicates the critical gelation temperature (CGT), see Figure 3.
This parameter is rather sensitive to the copolymer
concentration: a CGT of approximately 39 °C is observed for
an 11% w/w graft copolymer gel but this is reduced to less than
5 °C for a 15% w/w graft copolymer gel (see Figure 3B). Thus,
the CGT can be readily adjusted over a wide range of
physiologically relevant temperatures simply by varying the
copolymer concentration. A similar inverse relationship
between CGT and copolymer concentration was reported by
Madsen et al. for the analogous PHPMA−PMPC−PHPMA
triblock copolymer gels.31
Figure 2. Conversion versus time curves obtained from 1H NMR
studies of the synthesis of PMPC300-g-4(PHPMA50) at 70 °C prepared
using the TBTPB RAFT agent at 40% w/v solids (red circles) and
PMPC300 homopolymer under similar conditions (blue circles).
Figure 3. Temperature-dependent rheology data for a PMPC300-g-
4(PHPMA50) graft copolymer gel prepared via ATRP: (a) G and G
moduli determined for 10 and 13% w/v aqueous graft copolymer gels
from 2 to 50 °C at a heating rate of 3 °C min−1; (b) CGT values
determined for 10−15% w/v aqueous graft copolymer gels. Note that
increasing the copolymer concentration signiﬁcantly reduces the CGT.
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Copolymer gel biocompatibility was evaluated over 24 h by
placing copolymer gels in direct contact with a monolayer of
human dermal ﬁbroblast (HDF) cells. No discernible
detrimental eﬀect on cell viability was observed, see Figure 4.
These results were not unexpected, given that similar ﬁndings
had been reported previously by Bertal et al. for PHPMA−
PMPC−PHPMA triblock copolymer gels.32
To assess the antimicrobial activity of each copolymer, direct
contact assays were performed using each of the three strains of
S. aureus. First, various copolymer hydrogel dispersions/
solutions were placed on top of ﬁlms of S235, L9879, and
Oxford on agar gel. Typical results are shown in Figure 5. The
nongelling aqueous copolymer solution of 5% w/v PMPC300-g-
4(PHPMA50) did not inhibit bacterial growth but using the
same copolymer in the form of a 10% w/w free-standing gel
reduced bacterial growth, see Figure 5E, 5F. Similar results were
obtained for all three strains. This antimicrobial performance is
comparable to that observed for a 15% w/w PHPMA80−
PMPC400−PHPMA80 triblock copolymer gel prepared by
Madsen et al. (see Figure 5D),31 which suggests that the
graft copolymer architecture may be more eﬀective than a
triblock copolymer architecture. Importantly, the PMPC25−
PHPMA275 diblock copolymer worm gel did not exhibit any
discernible antimicrobial activity, even at a copolymer
concentration of 25% w/w (see Figure 5B). This indicates
that gelation alone is not suﬃcient to suppress bacterial growth.
Moreover, appropriate spatial location of the PHPMA chains is
clearly critical for antimicrobial activity. This interpretation is
supported by previous reported ﬁndings by Bertal and co-
workers, who found that planar surfaces coated with PHPMA
brushes exhibited antimicrobial activity, whereas those coated
with PMPC brushes did not.32
Confocal microscopy studies were undertaken using a well-
documented live/dead assay based on the combination of two
ﬂuorescent dye probes, SYTO 9 and propidium iodide (PI).56
The former dye stains live bacteria green, whereas the latter dye
stains dead bacteria red. S. aureus was mixed with a 12% w/v
cresyl violet-labeled graft copolymer gel [denoted PMPC300-g-
4(cvPHPMA50)] for 16 h at 37 °C, after which each gel was
cooled to produce a free-ﬂowing liquid. This enabled the
bacteria to be sedimented via centrifugation and hence isolated
for examination by confocal microscopy. Representative images
are shown in Figure 6, together with a positive control
comprising heat-treated dead bacteria and also untreated live
bacteria as a negative control. The ﬂuorescent cresyl violet label
signal (purple) is colocalized within the bacteria, suggesting
ingress of the copolymer chains within the micro-organism. As
expected, all heat-treated bacteria appeared red (dead) and all
live bacteria appeared green. Following exposure to the 12% w/
v solution of PMPC300-g-4(cvPHPMA50) graft copolymer, most
of the bacteria appeared dead with only a small number of
viable bacteria being observed. This provides the direct
experimental evidence that such PMPC300-g-4(PHPMA50)
graft copolymer gels are actually antibacterial, as opposed to
being merely bacteriostatic.
To further examine the mechanism of antimicrobial activity,
release of a cytoplasmic enzyme (lactate dehydrogenase, or
LDH) from the bacteria was assessed using a commercial
enzyme assay, see Figure 7. The positive control involved
exposure of bacteria to lysostaphin while the negative control
was simply a suspension of cells in PBS alone. Treating S.
aureus (S235) with either graft copolymer or lysostaphin
Figure 4. Cell viabilities for various copolymers determined over 24 h
using HDF cells measured with Alamar Blue. Copolymers were
utilized at their optimum concentrations in each case: the graft
copolymers were used at 12.5% w/v, while PMPC25−HPMA275 worm
gels were employed at 25% w/v. Copolymer gels were applied directly
on top of HDF monolayers in a thin layer (200 μL per 24-well plate)
which was supplemented with 200 mL 10% DMEM solution to ensure
that the cells did not dry out. Error bars = standard deviation, data
representative of n = 3.
Figure 5. “Drop-on” assay used to assess the antimicrobial activity of
various copolymers toward S. aureus (S235). Reduced growth within
the droplet area (see dotted line) indicates an inhibitory eﬀect toward
S. aureus. (a) PBS control; (b) 25% w/v PMPC25−PHPMA275 diblock
copolymer worm gel;16 (c,d) PHPMA88−PMPC400−PHPMA88 tri-
block copolymer gel13,14 utilized at 15% w/v and 20% w/v,
respectively; (e,f) PMPC300-g-4(PHPMA50) graft copolymer gel
utilized at 10% w/v and 5% w/v, respectively. Copolymers are
designated as “active” or “inactive” according to whether an
antimicrobial eﬀect is observed toward S. aureus growth with similar
results being obtained for all three strains investigated in this work.
Black dotted line indicates the droplet area, reduction of yellow
bacteria growth is indicated by the dark background. Images
representative of n = 3.
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resulted in a signiﬁcant increase in the concentration of
extracellular LDH, with the copolymer producing the greater
response. Thus, this assay provides good evidence that the graft
copolymer causes signiﬁcant damage to the bacterial mem-
brane. Presumably, the weakly hydrophobic PHPMA50 chains
penetrate the cell membrane, causing its rupture. This
bactericidal mechanism is not possible for the PMPC25−
PHPMA275 diblock copolymer worm gel because in this case its
relatively long PHPMA chains form the worm cores and hence
cannot interact with the bacteria.
TEM was used to examine whether there were any changes
in bacteria morphology upon treatment with copolymer gels.
Untreated S. aureus cells exhibit a well-deﬁned spherical
morphology, see Figure 7A, 7B. In contrast, S. aureus cells
Figure 6. Confocal laser scanning microscopy studies illustrating the live/dead assay for S. aureus [NCTC 6571 (Oxford) strain] after treatment with
a 12.5% w/v PMPC300-g-4(PHPMA50) graft copolymer gel. Copolymer-only (purple channel, top row of panels) shows isolation of the CV signal.
Heat-treated dead bacteria (red channel) are shown as a control in the second row of panels. Live bacteria are shown as a control in the red channel
(third row of panels). The fourth row of panels show copolymer-treated bacteria; overlays indicate colocalization of the copolymer with the dead
bacteria.
Figure 7. Exposure to a 10% w/v PMPC300-g-4(PHPMA50) graft copolymer gel causes bacterial membrane damage to S. aureus (S235 strain). LDH
release from this micro-organism is observed in the presence of both lysostaphin (positive control) and the graft copolymer, compared to a negative
control (PBS alone). TEM images indicate that compared to a control sample (A,B), the bacterial membrane is compromised for S. aureus treated
with either lysostaphin (C,D) or PMPC300-g-4(PHPMA50) (E,F). In addition, there is some evidence for the aggregation of bacteria when treated
with the PMPC300-g-4(PHPMA50) copolymer.
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treated with the lytic endopeptidase, lysostaphin, appeared as
“empty cell ghosts”, see Figure 7C, 7D.57,58 In contrast, bacteria
treated with 12.5% PMPC300-g-4(PHPMA50) are somewhat
deformed with apparent membrane shrinkage from the cell
wall, see Figure 7E, 7F. In addition, there is some evidence for
bacteria aggregation in the presence of the PMPC300-g-
4(PHPMA50) copolymer.
In principle, the antibacterial mechanism for the PMPC300-g-
4(PHPMA50) copolymer may be similar to that of cationic
surfactants. To examine this hypothesis, the concentration
dependence of the surface tension of dilute aqueous copolymer
solutions was determined and compared with that of
cetyltrimethylammonium bromide (CTAB).59 Such cationic
surfactants are known to kill micro-organisms by rupturing
bacterial cell membranes.19,21 Pure water has a surface tension
of 72 mN m−1 at 25 °C. As expected, CTAB had a relatively
low limiting surface tension of 36 mN m−1 at 1.0% w/w
concentration, see Figure 8. The PMPC300-g-4(PHPMA50)
copolymer exhibited a limiting surface tension of 49 mN m−1 at
1.0% w/w concentration, which is comparable to that obtained
for other non-ionic water-soluble polymers such as poly(N-
vinylpyrrolidone). This surface activity is attributed to
adsorption of the hydrophobic PHPMA chains at the air−
water interface because PMPC homopolymer causes little or no
lowering of the aqueous surface tension (see Figure 8).
Moreover, the PMPC25-PHPMA275 diblock copolymer worms
also exhibited much lower surface activity than that of the
PMPC300-g-4(PHPMA50) graft copolymer because in the
former case the PHPMA blocks are located within the worm
cores and hence are not available for adsorption at the air−
water interface. Thus, there is an obvious correlation between
surface activity and antimicrobial activity, which is consistent
with the proposed mechanism of action for the new PMPC300-
g-4(PHPMA50) graft copolymers described herein.
The present study has conﬁrmed that the spatial location of
the PHPMA chains plays a critical role in determining
antimicrobial activity toward S. aureus. The relatively long
PHPMA blocks present in the PMPC25−PHPMA275 diblock
copolymer self-assemble in aqueous solution to form the cores
of sterically stabilized worms, which leads to no detectable
antimicrobial activity. In contrast, the relatively short PHPMA
blocks present in the PHPMA−PMPC−PHPMA triblock
copolymers previously reported by Madsen et al. and in the
PMPC300-g-4(PHPMA50) graft copolymers described herein are
suﬃciently hydrophobic and surface-active to rupture bacterial
membranes. There is some evidence that the new graft
copolymer architecture is more potent than the triblock
copolymer architecture reported previously. In summary, we
have established that gelation alone is not suﬃcient to kill S.
aureus but it is not yet clear whether gelation enhances
antimicrobial activity. Finally, one reviewer of this manuscript
has suggested that the microstructure of these graft copolymers
could also aﬀect their antimicrobial performance. This
interesting hypothesis also clearly warrants further work.
■ CONCLUSIONS
Inhibition of bacterial growth can be achieved using the new
PMPC-g-PHPMA graft copolymer gel described herein.
Moreover, there is some evidence that this new copolymer
architecture may be more eﬀective than the PHPMA−PMPC−
PHPMA triblock copolymer gels described previously.
Importantly, new control experiments conducted using
biocompatible PMPC25-b-PHPMA275 diblock copolymer
worm gels conﬁrm that no antibacterial activity is observed in
this case. Thus, the spatial location of the PHPMA chains is
clearly critical for the observation of antimicrobial activity and
gelation alone is not suﬃcient to inhibit bacterial growth. A
confocal microscopy-based live/dead assay provides evidence
that PMPC300-g-4(PHPMA50) graft copolymer gel does indeed
kill micro-organisms, rather than merely retarding their growth.
It is postulated that the weakly hydrophobic PHPMA chains
penetrate the bacterial membrane and hence induce rupture, as
indicated by the in situ release of LDH. TEM studies provide
evidence for bacteria aggregation, while confocal microscopy
studies conducted using a ﬂuorescently labeled graft copolymer
conﬁrm its interaction with the micro-organism. It is
emphasized that this new antibacterial graft copolymer gel
exhibits relatively low cytotoxicity toward mammalian cells.
Given its thermoreversible gelation behavior, it may also oﬀer
some potential as an inherently antibacterial smart wound
dressing.
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(15) Muñoz-Bonilla, A.; Fernańdez-García, M. Prog. Polym. Sci. 2012,
37, 281−339.
(16) Siedenbiedel, F.; Tiller, J. C. Polymers 2012, 4, 46−71.
(17) Palermo, E. F.; Kuroda, K. Appl. Microbiol. Biotechnol. 2010, 87,
1605−1615.
(18) Nederberg, F.; Zhang, Y.; Tan, J. P. K.; Xu, K.; Wang, H.; Yang,
C.; Gao, S.; Guo, X. D.; Fukushima, K.; Li, L.; Hedrick, J. L.; Yang, Y.-
Y. Nat. Chem. 2011, 3, 409−414.
(19) Lenoir, S.; Pagnoulle, C.; Detrembleur, C.; Galleni, M.; Jeŕôme,
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